HOB Biotech Group Corp.,Ltd reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 146.62 million compared to CNY 143.42 million a year ago. Revenue was CNY 151.28 million compared to CNY 147.54 million a year ago.

Net income was CNY 24.36 million compared to CNY 45.08 million a year ago. Basic earnings per share from continuing operations was CNY 0.3863 compared to CNY 0.746 a year ago. Diluted earnings per share from continuing operations was CNY 0.3834 compared to CNY 0.746 a year ago.